sgRNA guide sequence of specific targeting mouse Gdf5 gene and application thereof

A species-specific, mouse-based technology, applied in the fields of medical genetics and molecular biology, can solve the problem of lack of sgRNA guide sequence, etc., and achieve the effect of facilitating drug screening of positive transfected cells, increasing the number and high concentration

Active Publication Date: 2020-03-06
GUILIN MEDICAL UNIVERSITY
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is currently no sgRNA guide sequenc...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • sgRNA guide sequence of specific targeting mouse Gdf5 gene and application thereof
  • sgRNA guide sequence of specific targeting mouse Gdf5 gene and application thereof
  • sgRNA guide sequence of specific targeting mouse Gdf5 gene and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0076] The principles and features of the present invention will be described below in conjunction with specific drawings, and the examples given are only used to explain the present invention, not to limit the scope of the present invention.

[0077] 1. Screening of the pathogenic mutation site of the human Gdf5 gene, and confirming that glycine (G for short) at position 70 of the human Gdf5 gene is a pseudo-mutation site.

[0078] SYM1 is caused by mutations in the GDF5 gene, and two pathogenic mutations were detected by screening the OMIM online database (as shown in Table 1). Due to the limited mutation sites included in OMIM, the present invention also utilizes the ExAC database to screen the mutation situation of the human GDF5 gene, and screens 164 mutation sites altogether (as shown in Table 2 and figure 1 shown). Then, the ClinVar database was used to search the pathogenicity of GDF5 missense mutations, and a total of 3 mutation sites were retrieved (as shown in Tabl...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an sgRNA guide sequence of a specific targeting mouse Gdf5 gene and an application thereof, which belong to the technical field of medical genetics and molecular biology. A nucleotide sequence corresponding to the sgRNA is a sequence as shown in SEQ ID NO. 1. The invention also discloses a method for editing the mouse Gdf5 gene by using the sgRNA guide sequence of the specific targeting mouse Gdf5 gene. The sgRNA guide sequence disclosed by the invention can mediate Cas9 protein to efficiently cut target DNA, so that the sgRNA guide sequence is used for editing the mouse Gdf5 gene to influence the function of the mouse Gdf5 gene encoding protein. According to the sgRNA guide sequence, efficient targeting can be achieved through a CRISPR/Cas9 system, and the efficiency is 100%.

Description

technical field [0001] The invention relates to a sgRNA guide sequence specifically targeting mouse Gdf5 gene and application thereof, belonging to the technical fields of medical genetics and molecular biology. Background technique [0002] The CRISPR / Cas system was first discovered in bacteria, and it performs acquired immune functions in eubacteria and archaea, which can resist the invasion of foreign viruses and plasmids. People have modified the CRISPR / Cas system of the microorganism itself by means of genetic engineering, thereby creating a targeting system that can be widely used in gene editing of higher organisms, the CRISPR / Cas9 system. Since the system came out in 2012, it has injected strong impetus into life science and biomedical research, and has become a research hotspot in recent years. Since 2013, researchers have successfully edited the genome in mammalian cells by using the DNA binding activity and endonuclease activity of CRISPR / Cas9. In the CRISPR / Cas...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N15/113C12N15/85C12N15/10C12N15/12C12Q1/02
CPCC07K14/51C12N15/102C12N15/1136C12N15/85C12N2503/02C12N2800/107C12N2310/20G01N33/5008G01N2500/10
Inventor 于鸿浩肖福英韦日明岳鹏鹏王添贤
Owner GUILIN MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap